A Study Evaluating the Diagnostic Yield and Safety of the ProCore vs Conventional EBUS-TBNA Needle in Subjects With Suspected Sarcoidosis

Inclusion Criteria: Patients meeting all the following criteria will be eligible for inclusion in the study: * Age group of 18 to 75 years * Clinicoradiological suspicion of sarcoidosis where EBUS-TBNA is being planned * Enlarged hilar and mediastinal lymph nodes \>10 mm (any axis) on computed tomography of the chest * Ability to provide informed consent to participate in the study Exclusion Criteria: Patients with any of the following will be excluded: * Hypoxemia (SpO2 \<92% on FiO2 of 0.3) * Treatment with systemic glucocorticoids for \>2 weeks in the preceding three months * Diagnosis of sarcoidosis possible with another minimally invasive technique such as skin biopsy or peripheral lymph node biopsy * Failure to provide informed consent